(Q36641362)

English

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

scientific article published on February 2000

In more languages
default for all languages
No label defined

No description defined

Statements

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit